PREVIOUS
✖
New Strategy to Combat Antimalarial Drug Resistance in Africa
December 15 , 2022
703 days
502
0
- World Health Organization unveiled a new strategy to combat antimalarial drug resistance in Africa.
- Africa is currently highly dependent on artemisinin-based combination therapies (ACT).
- Resistance to artemisinin and the partner drug in ACT therapy result in an increase in treatment failure rates.
- This can cause a major hurdle in the global fight against malaria.
- The new WHO seeks to minimize consequences of antimalarial drug resistance in Africa through four pillars strategy.
Leave a Reply
Your Comment is awaiting moderation.